Driving Innovation, Digitalization, and DEI – A Conversation with Christine HortonFebruary 24, 2023 Driving Innovation, Digitalization, and DEI – A Conversation with Christine Horton
SpineThera Announces Results for SX600 from its SALIENT Phase 2 Sciatica Pain Clinical Trial Supporting the Potential for Best-In-Class TherapyDecember 7, 2022 SpineThera Announces Results for SX600 from its SALIENT Phase 2 Sciatica Pain Clinical Trial Supporting the Potential for Best-In-Class Therapy
FDA Clearance For PADnet Xpress For Home UseDecember 5, 2022 FDA Clearance For PADnet Xpress For Home Use
Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung CancerNovember 29, 2022 Vergent Bioscience Awarded National Cancer Institute Phase 2 Grant to Advance Clinical Development of VGT-309 in Lung Cancer
NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day UseOctober 25, 2022 NeuroOne® Receives FDA 510(k) Clearance to Market its Evo® sEEG System for Less than 30 Day Use
OpSens Gets FDA Clearance for the SavvyWire for Use in TAVR ProceduresSeptember 15, 2022 OpSens Gets FDA Clearance for the SavvyWire for Use in TAVR Procedures
Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor PatientsSeptember 7, 2022 Monteris Medical Announces First Patient Enrolled in REMASTer Clinical Study on NeuroBlate® System for Metastatic Brain Tumor Patients